Gene Testing Could Help Some Breast Cancer Patients Avoid Chemotherapy

Whether some women with breast cancer can safely forgo chemotherapy without increasing the risk of recurrence has been a focus of research for years. Gene-based testing offers a way to help doctors assess who may benefit from the treatment and who may be able to avoid it.

These tests examine the activity of genes in a tumour, providing information about its biological behaviour. For selected patients, the results can help estimate the likelihood of the cancer returning and guide decisions about whether chemotherapy would offer a meaningful benefit.

The approach is not suitable for every breast cancer case. Doctors must consider test findings alongside factors such as the type and stage of the cancer, as well as the patient’s overall health, rather than treating a result as a stand-alone instruction to stop or skip treatment.

Avoiding chemotherapy when it is unlikely to help could spare patients its side effects and treatment burden. But omitting chemotherapy does not mean abandoning cancer care: other treatments and follow-up may still be necessary.

The goal is more personalised treatment, not a blanket move away from chemotherapy. Patients considering gene-based testing should discuss its suitability and limitations with their cancer care team before making treatment decisions.